378 related articles for article (PubMed ID: 29510720)
1. The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.
Kim H; Lin Q; Glazer PM; Yun Z
Breast Cancer Res; 2018 Mar; 20(1):16. PubMed ID: 29510720
[TBL] [Abstract][Full Text] [Related]
2. The Inhibitory Effect of Curcumin on Hypoxia Inducer Factors (Hifs) as a Regulatory Factor in the Growth of Tumor Cells in Breast Cancer Stem-Like Cells.
Sarighieh MA; Montazeri V; Shadboorestan A; Ghahremani MH; Ostad SN
Drug Res (Stuttg); 2020 Nov; 70(11):512-518. PubMed ID: 32961574
[TBL] [Abstract][Full Text] [Related]
3. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
4. Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER-α status.
Harrison H; Rogerson L; Gregson HJ; Brennan KR; Clarke RB; Landberg G
Cancer Res; 2013 Feb; 73(4):1420-33. PubMed ID: 23248117
[TBL] [Abstract][Full Text] [Related]
5. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
[TBL] [Abstract][Full Text] [Related]
6. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Weitzenfeld P; Meshel T; Ben-Baruch A
Oncotarget; 2016 Dec; 7(49):81123-81143. PubMed ID: 27835603
[TBL] [Abstract][Full Text] [Related]
10. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
12. The hypoxic tumor microenvironment in vivo selects tumor cells with increased survival against genotoxic stresses.
Kim H; Lin Q; Yun Z
Cancer Lett; 2018 Sep; 431():142-149. PubMed ID: 29859297
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells.
García-Venzor A; Mandujano-Tinoco EA; Lizarraga F; Zampedri C; Krötzsch E; Salgado RM; Dávila-Borja VM; Encarnación-Guevara S; Melendez-Zajgla J; Maldonado V
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118523. PubMed ID: 31401107
[TBL] [Abstract][Full Text] [Related]
14. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
15. Two-photon fluorescent probe for detection of nitroreductase and hypoxia-specific microenvironment of cancer stem cell.
Liu Y; Liu W; Li H; Yan W; Yang X; Liu D; Wang S; Zhang J
Anal Chim Acta; 2018 Sep; 1024():177-186. PubMed ID: 29776544
[TBL] [Abstract][Full Text] [Related]
16. Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells.
Pang MF; Siedlik MJ; Han S; Stallings-Mann M; Radisky DC; Nelson CM
Cancer Res; 2016 Sep; 76(18):5277-87. PubMed ID: 27503933
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.
Jacobsson H; Harrison H; Hughes É; Persson E; Rhost S; Fitzpatrick P; Gustafsson A; Andersson D; Gregersson P; Magnusson Y; Ståhlberg A; Landberg G
Mol Oncol; 2019 Aug; 13(8):1693-1705. PubMed ID: 31066211
[TBL] [Abstract][Full Text] [Related]
18. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
19. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.
Lin Q; Yun Z
Cancer Biol Ther; 2010 Jun; 9(12):949-56. PubMed ID: 20581454
[TBL] [Abstract][Full Text] [Related]
20. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.
Ma Y; Hao X; Zhang S; Zhang J
Breast Cancer Res Treat; 2012 Jun; 133(2):473-85. PubMed ID: 21947651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
